TR200100364T2 - Yeni bileşimler. - Google Patents

Yeni bileşimler.

Info

Publication number
TR200100364T2
TR200100364T2 TR2001/00364T TR200100364T TR200100364T2 TR 200100364 T2 TR200100364 T2 TR 200100364T2 TR 2001/00364 T TR2001/00364 T TR 2001/00364T TR 200100364 T TR200100364 T TR 200100364T TR 200100364 T2 TR200100364 T2 TR 200100364T2
Authority
TR
Turkey
Prior art keywords
4alkyl
hydrogen
alkyl
6alkyl
halogen
Prior art date
Application number
TR2001/00364T
Other languages
English (en)
Inventor
Coulton Steven
Novelli Riccardo
Alan Porter Roderick
Thompson Mervyn
William Ward Robert
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200100364T2 publication Critical patent/TR200100364T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

m nin 1 veya2;n nin 1 veya 2; X in CH veya N; oldugu Y nin hidrojen, halojen, siyano, CF3,alkil veya alkoksi'den seçildigi; R1'yi doymus halka sistemi içinde herhangi bir pozisyonda olup, hidrojen veya ayni veya farkli olup her birinin fluoro ve C1-6 alkilden seçilen en çok iki ikame oldugu; R2'nin hidrojen veya halojen, NO2, CN, N3, CF3O-, CF3S-, CF3CO-, C1-6alkil, C1-6alkenil, C1-6alkinil, C1-6 perfluoroalkil, C3-6sikloalkil, C3-6sikloalkil-C1-4alkil-, C1-6alkil O-, -C1-6alkilCO-, C3-6sikloalkil O-, C3-6sikloalkil CO-, C3-6sikloalkil-C1-4alkilO-, C1-4 alkilO-, C3-6 sikloalkil-C1-4alkilCO-,fenil, fenoksi, benziloksi, benzoil, fenil-C1-4alkil-, C1-6alkilS-, C1-6alkilSO2-, (C1-4alkil)2NSO2-, (C1-4alkil)NHSO2-, (C1-4alkil)2NCO-, oksazolo, (C1-4alkil)NHCO-,CONH2 den seçilen en çok 4 ikame oldugu; veya R4'ün hidrojen veya C1-4 alkil ve R5'in R5 hidrojen, C1-4alkil, (formül), -C02C1-4alkil veya -C0C1-4alkil; oldugu R4CONH-veya NR4R5 oldugu; veya iki R2 grubunun birleserek (DEVAMI VAR).
TR2001/00364T 1998-08-05 1999-08-03 Yeni bileşimler. TR200100364T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9817028.5A GB9817028D0 (en) 1998-08-05 1998-08-05 Novel compounds

Publications (1)

Publication Number Publication Date
TR200100364T2 true TR200100364T2 (tr) 2001-09-21

Family

ID=10836742

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00364T TR200100364T2 (tr) 1998-08-05 1999-08-03 Yeni bileşimler.

Country Status (26)

Country Link
EP (1) EP1102769B1 (tr)
JP (1) JP2002522436A (tr)
KR (1) KR20010072262A (tr)
CN (1) CN1324359A (tr)
AR (1) AR020002A1 (tr)
AT (1) ATE237615T1 (tr)
AU (1) AU754638B2 (tr)
BR (1) BR9912707A (tr)
CA (1) CA2339362A1 (tr)
CO (1) CO5080783A1 (tr)
CZ (1) CZ293667B6 (tr)
DE (1) DE69906985T2 (tr)
DK (1) DK1102769T3 (tr)
ES (1) ES2197665T3 (tr)
GB (1) GB9817028D0 (tr)
HK (1) HK1037919A1 (tr)
HU (1) HUP0103311A3 (tr)
IL (1) IL141164A0 (tr)
NO (1) NO20010584L (tr)
NZ (1) NZ509685A (tr)
PL (1) PL346167A1 (tr)
PT (1) PT1102769E (tr)
TR (1) TR200100364T2 (tr)
TW (1) TW518334B (tr)
WO (1) WO2000008020A2 (tr)
ZA (1) ZA200100902B (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013318182C1 (en) 2012-09-18 2022-01-20 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
US9550780B2 (en) 2012-09-18 2017-01-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
WO2015077521A1 (en) * 2013-11-22 2015-05-28 Auspex Pharmaceuticals, Inc. Benzoquinoline inhibitors of vesicular monoamine transporter 2
MX369956B (es) 2013-12-03 2019-11-27 Auspex Pharmaceuticals Inc Metodos para preparar compuestos de benzoquinolina.
IL305352A (en) 2015-03-06 2023-10-01 Auspex Pharmaceuticals Inc Methods for treating abnormal movement disorders
CN108912118A (zh) * 2018-07-12 2018-11-30 新乡学院 一种四氢异喹啉并三嗪骨架化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0067565A1 (en) * 1981-06-16 1982-12-22 Beecham Group Plc Pharmaceutically active compounds

Also Published As

Publication number Publication date
ATE237615T1 (de) 2003-05-15
AR020002A1 (es) 2002-03-27
PT1102769E (pt) 2003-08-29
IL141164A0 (en) 2002-11-10
PL346167A1 (en) 2002-01-28
CA2339362A1 (en) 2000-02-17
JP2002522436A (ja) 2002-07-23
TW518334B (en) 2003-01-21
EP1102769B1 (en) 2003-04-16
NO20010584D0 (no) 2001-02-02
CZ293667B6 (cs) 2004-06-16
AU5509899A (en) 2000-02-28
DK1102769T3 (da) 2003-08-11
ES2197665T3 (es) 2004-01-01
GB9817028D0 (en) 1998-09-30
NZ509685A (en) 2003-07-25
WO2000008020A8 (en) 2001-04-26
AU754638B2 (en) 2002-11-21
DE69906985D1 (en) 2003-05-22
EP1102769A2 (en) 2001-05-30
HUP0103311A2 (hu) 2002-02-28
KR20010072262A (ko) 2001-07-31
HK1037919A1 (en) 2002-02-22
DE69906985T2 (de) 2004-02-12
CZ2001436A3 (cs) 2001-08-15
WO2000008020A2 (en) 2000-02-17
WO2000008020A3 (en) 2000-07-13
CO5080783A1 (es) 2001-09-25
NO20010584L (no) 2001-02-02
HUP0103311A3 (en) 2002-10-28
ZA200100902B (en) 2002-05-14
CN1324359A (zh) 2001-11-28
BR9912707A (pt) 2001-11-06

Similar Documents

Publication Publication Date Title
ATE60571T1 (de) Inden-analoga von mevalonolakton und ihre derivate.
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
PE20021091A1 (es) Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
TR200402069T4 (tr) Difenilüre türevleri ve bunların alfa 2/5-HT2c antagonisti olarak kullanılması
ATE388130T1 (de) C10-alkanolalkoxylate und ihre verwendung
ATE258790T1 (de) Z-styryl sulfonen als anti-krebsmittel
TR200100364T2 (tr) Yeni bileşimler.
DK1086096T3 (da) Benzamider med tetrahydrofuranyloxy-substituenter som inhibitorer af phosphodiesterase 4
KR850001755A (ko) 디히드로 이미다조피롤로피리딘류의 제조방법
EA200200810A1 (ru) Конденсированные соединения азола и их применение в качестве гипогликаемических агентов
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
DE69910568D1 (de) Furopyridinderivate und ihre therapeutische verwendung
ATE44648T1 (de) Antihypertensives kombinationspraeparat.
NO995289L (no) Benzimidazol-derivater
ES8103573A1 (es) Procedimiento para la preparacion de fenoxi y tiofenoxinitrilos.
ATE266026T1 (de) Benzofurancarboxamide und deren therapeutische verwendung
TR200000057T2 (tr) 6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları.
NO942920D0 (tr)
DK108387D0 (da) Fremgangsmaade til fremstilling af phenoxyalkanoltriazolforbindelser og mellemprodukter dertil
AU521927B2 (en) Stilbene type of optical brightener
TR199801839T2 (tr)
TH58885B (th) ฟอสฟิไนท์
TH2764A (th) N-ฟอสฟอริล-หรือ N-ไธโอฟอสฟอริล-N'-s-ไตรอาซินิล-ฟอร์มามิดีนชนิดใหม่
TH2764EX (th) N-ฟอสฟอริล-หรือ N-ไธโอฟอสฟอริล-N'-s-ไตรอาซินิล-ฟอร์มามิดีนชนิดใหม่
FI871984A0 (fi) 3-aminodihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.